Status:
COMPLETED
A Study To Investigate The Absorption, Metabolism And Excretion Of [14C] PD 0200390 In Six Healthy Male Volunteers
Lead Sponsor:
Pfizer
Conditions:
Insomnia
Eligibility:
All Genders
18-65 years
Phase:
PHASE1
Brief Summary
To determine the mass balance of PD 0200390
Eligibility Criteria
Inclusion
- Healthy
Exclusion
- unhealthy, or concomitant meds
Key Trial Info
Start Date :
May 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2008
Estimated Enrollment :
6 Patients enrolled
Trial Details
Trial ID
NCT00722306
Start Date
May 1 2008
End Date
May 1 2008
Last Update
February 4 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Pfizer Investigational Site
New Haven, Connecticut, United States, 06511